Tic Network Localization and DBS
Dr. Jeff Ratliff talks with Dr. Christos Ganos about the use of brain lesion network mapping to interrogate whether tic disorder-inducing lesions are associated with a common network in the average hu...
7 Maalis 202222min
Generic Competition for Dimethyl Fumarate
Dr. Jason Crowell talks with 46brooklyn Research CEO Antonio Ciaccia about how Medicare Part D has hidden the benefits of generic competition for Tecfidera, a disease-modifying therapy for multiple sc...
3 Maalis 202220min
March 2022 Neurology Recall: Prognosis and Treatment of Guillain-Barré Syndrome
The March 2022 replay of past episodes showcases a selection of interviews regarding the prognosis and treatment of Guillain-Barré syndrome. This episode features Drs. Ted Burns, Jeff Ratliff, and Mic...
2 Maalis 202238min
Equal Pay for Women Neurologists: Show Us the Money!
Dr. Tesha Monteith talks with Dr. Elizabeth Loder about her editorial on the gender pay gap in academic neurology and its impact on women neurologists as well as the field at large. Read the full arti...
28 Helmi 202213min
Shared Genetics of Migraine, Stroke, and Cervical Dissection
Dr. Andy Southerland talks with Dr. Daniel Chasman about the shared genetic risk of migraine, stroke, and cervical artery dissection (CeAD), a triad of neurologic disorders with vascular involvement. ...
24 Helmi 202212min
Seizure Frequency in Pregnancy
Dr. Halley Alexander discusses whether epilepsy type, seizure location, or antiseizure medications influence seizure frequency during pregnancy and postpartum with Dr. P. Emanuela Voinescu. Read the ...
21 Helmi 202216min
GFAP Autoimmune Syndrome
Dr. Stacey Clardy discusses the clinical, biological, and imaging features—as well as the overall clinical course—of a French cohort of patients with glial fibrillar acidic protein (GFAP) autoantibodi...
17 Helmi 202215min
Pharmacy Benefits and Disease-Modifying Therapies
Dr. Justin Abbatemarco talks with Dr. Daniel Hartung about the impact of Medicare Part D plan disease-modifying therapy restrictiveness upon adherence and outcomes among patients with multiple scleros...
14 Helmi 202220min
